In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dactinomicina Drug Master File in Korea (Dactinomicina KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dactinomicina. The MFDS reviews the Dactinomicina KDMF as part of the drug registration process and uses the information provided in the Dactinomicina KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dactinomicina KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dactinomicina API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dactinomicina suppliers with KDMF on PharmaCompass.